Journal of the Neurological Sciences
Volume 277, Issue 1 , Pages 187-190 , 15 February 2009

Is there need to search for alternatives to indomethacin for hemicrania continua? Case reports and a review

  • Sanjay Prakash

      Affiliations

    • Department of Neurology, Medical College, SSG Hospital, Baroda, Gujarat 390001, India
    • Corresponding Author InformationCorresponding author. O-19, Doctor's Quarter, Jail Road, Baroda, Gujarat 390001, India. Tel.: +919898129484; fax: +91 02692 258700.
    • ,
  • Mahammed Husain

      Affiliations

    • Department of Medicine, Medical College, SSG Hospital, Baroda, Gujarat 390001, India
    • ,
  • Dhara S Sureka

      Affiliations

    • Department of Neurology, Medical College, SSG Hospital, Baroda, Gujarat 390001, India
    • ,
  • Nimish P Shah

      Affiliations

    • Department of Neurology, Medical College, SSG Hospital, Baroda, Gujarat 390001, India
    • ,
  • Nilima D Shah

      Affiliations

    • Medical College, SSG Hospital, Baroda, Gujarat, India

Received 11 August 2008 ,Revised 23 October 2008 ,Accepted 31 October 2008.

References 

  1. Headache Classification Committee of the InternationalHeadache Society . In: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. 2nd ed.. Cephalalgia. vol. 24:2004;p. 1–160
  2. Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs. 2003;63(16):1637–1677
  3. Ong CKS, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19–34
  4. Wolff MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Eng J Med. 1999;340(24):1888–1899
  5. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 1993;43:1609–1611
  6. Peres MF, Silberstein SD, Nahimas S, Shechter AL, Youssef I, Rozen TD, et al. Hemicrania continua is not that rare. Neurology. Sep 25 2001;57(6):948–951
  7. Newman LC, Lipton RB, Solomon S. Hemicrania continua: ten new cases and a review of the literature.. Neurology. 1994;44:2111–2114
  8. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM. Hemicrania continua: a report of ten cases. Arq. Neuro-Psiqiatr. 2002;60(3 B):695–698
  9. Espada F, Escalza I, Morales-Asin F, Navas I, Inignez C, Mauri JA. Hemicrania continua: nine new cases. Cephalalgia. 1999;19:442;Abstract
  10. Peres MFP, Silberstein SD. Hemicrania continua responds to cyclo oxygenase-2 inhibitors. Headache. 2002;42:530–531
  11. Pareja JA, Caminero AB, Franco E, Casado JL, Pascual J, Sanchez del rio M. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia. 2001;21:906–910
  12. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539–545
  13. Sjaastad O. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases. J Headache Pain. 2006;7:151–156
  14. Bateman DN, Kennedy JG. Non-steroidal anti-inflammatory drugs and elderly. BMJ. 1995;310:817–818
  15. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua: two case reports. Clin Neurol Neurosurg. 2008;110:88–90
  16. Rozen TD. Melatonin responsive hemicrania continua. Headache. 2006;46:1203–1204
  17. Spears RC. Hemicrania Continua: a case in which a patient experienced complete relief on melatonin. Headache. 2006;46:524–527
  18. Trucco M, Antonaci F, Sandrini G. Hemicrania continua: a case responsive to piroxicam-beta–cyclodextrin. Headache. 1992;32:39–40
  19. Kumar KL, Bordiuk JD. Hemicrania continua: a therapeutic dilemma. Headache. 1991;31:345
  20. Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache. 1995;35:549–550
  21. Bordini C, Antonaci F, Stovner LJ, et al. ‘Hemicrania continua’ a clinical review. Headache. 1991;31:20–26
  22. Peres MFP, Zukerman E. Hemicrania continua responsive to rofecoxib. Cephalalgia. 2000;20:130–131
  23. Mariano da Silva H, Alcantara MC, Bordini CA, Speciali JG. Strictly unilateral headache reminiscent of hemicrania continua resistant to indomethacin but responsive to gabapentin. Cephalalgia. 2002;22:409–410
  24. Rajabally YA, Jacob S. Hemicrania continua responsive to verapamil. Headache. 2005;45:1082–1083
  25. Peres MFP, Zukerman E. Hemicrania continua responsive to rofecoxib. Cephalalgia. 2000;20:130–131
  26. Spears RC. Efficacy of Gabapentine in the treatment of hemicrania contiua. Headache. 2008;S1:S66;(Abstract)
  27. Pareja JA, Antonaci F, Vincent M. The hemicrania continua diagnosis. Cephalalgia. 2001;21:940–946
  28. MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ. 1997;315:1333–1337
  29. Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology. 2000;54(suppl 4):S2–S6
  30. Klebe S, Stolze H, Grensing K, Volkmann J, Wenzelburger R, Deuschl G. Influence of alcohol on gait in patients with essential tremor. Neurology. 2005;65:96–101
  31. Kuritzky A. Indomethacin-resistant hemicrania continua. Cephalalgia. 1992;12:57–59
  32. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997;120:193–209
  33. Matharu MS, Bradury P, Swash M. Hemicrania continua: side alteration and response to topiramate. Cephalalgia. 2006;26:341–344
  34. Brighina F, Palermo A, Consentino G, Fierro B. Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate. Headache. 2007;47:441–443

☆ This manuscript was not presented at any meeting or published, nor is being considered for publication elsewhere.

☆☆ Written informed consent was taken from the patients to publish the report.

PII: S0022-510X(08)00562-5

doi: 10.1016/j.jns.2008.10.027

Journal of the Neurological Sciences
Volume 277, Issue 1 , Pages 187-190 , 15 February 2009

Article Tools